ES462389A1 - Procedimiento para la obtencion de 1-amino-2-hidroxi-3-hete-rocicliloxi-propanos. - Google Patents

Procedimiento para la obtencion de 1-amino-2-hidroxi-3-hete-rocicliloxi-propanos.

Info

Publication number
ES462389A1
ES462389A1 ES462389A ES462389A ES462389A1 ES 462389 A1 ES462389 A1 ES 462389A1 ES 462389 A ES462389 A ES 462389A ES 462389 A ES462389 A ES 462389A ES 462389 A1 ES462389 A1 ES 462389A1
Authority
ES
Spain
Prior art keywords
cyanopyridine
dimethoxyphenyl
propanes
heterocyclyloxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES462389A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES462389A1 publication Critical patent/ES462389A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento para la obtención de 1-amino-2-hidroxi-3-heterociclicloxi-propanos de fórmula ***(Ver fórmula I), donde Y significa el grupo -CH= o el grupo -N=, R1 significa hidrógeno, hidroxi, alquilo inferior o alcoxi inferior, R2 significa hidroxi, alcoxi inferior o junto con R1 o-alquilideno inferior-dioxi o o-alquilideno inferior-dioxi y R3 significa alquilo inferior, alcoxi inferior, halógeno o ciano, donde los restos R1, R2 y R3 están en cada caso enlazados a uno de los átomos de carbono aromáticos posibles arbitrario.
ES462389A 1976-10-05 1977-09-15 Procedimiento para la obtencion de 1-amino-2-hidroxi-3-hete-rocicliloxi-propanos. Expired ES462389A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1263576A CH607585A5 (en) 1976-10-05 1976-10-05 Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine

Publications (1)

Publication Number Publication Date
ES462389A1 true ES462389A1 (es) 1978-07-01

Family

ID=4384944

Family Applications (1)

Application Number Title Priority Date Filing Date
ES462389A Expired ES462389A1 (es) 1976-10-05 1977-09-15 Procedimiento para la obtencion de 1-amino-2-hidroxi-3-hete-rocicliloxi-propanos.

Country Status (21)

Country Link
JP (1) JPS5350177A (es)
AT (1) AT358037B (es)
AU (1) AU514676B2 (es)
BE (1) BE858867A (es)
CA (1) CA1105021A (es)
CH (1) CH607585A5 (es)
DE (1) DE2740678A1 (es)
DK (1) DK402877A (es)
ES (1) ES462389A1 (es)
FI (1) FI772681A (es)
FR (1) FR2367065A1 (es)
GB (1) GB1591723A (es)
GR (1) GR71677B (es)
IE (1) IE45692B1 (es)
IL (1) IL53013A (es)
NL (1) NL7710394A (es)
NO (1) NO773125L (es)
NZ (1) NZ185267A (es)
PT (1) PT67048B (es)
SE (1) SE7710250L (es)
ZA (1) ZA775698B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
DE3776011D1 (de) * 1986-06-30 1992-02-27 Toyo Jozo Kk 2-substituierte alkoxy-3-substituierte pyrazine.
AU1580001A (en) * 1999-11-15 2001-05-30 Eli Lilly And Company Process for the preparation of aryloxy propanolamines

Also Published As

Publication number Publication date
CA1105021A (en) 1981-07-14
BE858867A (fr) 1978-03-20
AT358037B (de) 1980-08-11
IE45692L (en) 1978-04-05
ATA648777A (de) 1980-01-15
AU514676B2 (en) 1981-02-19
CH607585A5 (en) 1978-09-15
JPS5350177A (en) 1978-05-08
PT67048B (de) 1979-02-16
AU2912577A (en) 1979-04-05
IL53013A (en) 1981-09-13
ZA775698B (en) 1978-05-30
NO773125L (no) 1978-04-06
PT67048A (de) 1977-10-01
IE45692B1 (en) 1982-10-20
IL53013A0 (en) 1977-11-30
FI772681A (fi) 1978-04-06
DK402877A (da) 1978-04-06
FR2367065A1 (fr) 1978-05-05
NZ185267A (en) 1979-07-11
GB1591723A (en) 1981-06-24
FR2367065B1 (es) 1980-10-10
GR71677B (es) 1983-06-21
DE2740678A1 (de) 1978-04-06
SE7710250L (sv) 1978-04-06
NL7710394A (nl) 1978-04-07

Similar Documents

Publication Publication Date Title
ATE49195T1 (de) Herstellung von fibraten.
PT1075259E (pt) Novos analogos gordos para o tratamento de diabetes
FR2392007A1 (fr) 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy-piperidines, leurs derives, leur preparation et leur utilisation comme antidiarrheiques et analgesiques
PT775117E (pt) Analogos de 2-nitroimidazole fluorinados para detectar celulas de tumor hipoxicas
MY101940A (en) Chemical compounds
ES544748A0 (es) Procedimiento para preparar cetonas heterociclicas nitroge- nadas con anillo de siete miembros y condensadas
ATE48835T1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
ES462389A1 (es) Procedimiento para la obtencion de 1-amino-2-hidroxi-3-hete-rocicliloxi-propanos.
ES543786A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dietilaminoalcoxi sustituido y sus sales deadicion acidas y amonicas cuaternarias
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
FI88795B (fi) Foerfarande foer framstaellning av tienyletylaminer
ES466850A1 (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-imi- dazolidinilidenbenzamina.
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
ES493375A0 (es) Procedimiento para la preparacion de mezclas de aclaradores opticos
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
DK340478A (da) Fremgangsmaade til fremstilling af dibenzo (d,g)-(1,3,6)dioxazocinderivater eller syreadditionssalte deraf
FR2398074A1 (fr) Lactones obtenues en cyclisant des composes de n-(2-hydroxyalkyl)-n-phosphonomethylglycine, et leur utilisation comme herbicides
ES511836A0 (es) "procedimiento para la preparacion de nuevos a1-pirrolin-tiolactimeteres".
JPS53137931A (en) Novel cyclic sestaterpenes
DK73278A (da) Fremgangsmaade til fremstilling af ( +,-)-cis-alfa-(3-(2,6-dimethyl-1-piperidinyl)-alfaphenyl-2-pyridinmethanol eller syreadditionssalte heraf
ES8704947A1 (es) Un procedimiento para preparar un derivado de imidazopirida-zina
FI904033A0 (fi) Nya 1,3-oxaziner.
IE44951L (en) Pyridoindoles
JPS53137933A (en) Novel cyclic sestaterpeneketones
JPS53149932A (en) 2-(3-alkylnitrosoureido)-hexapyranoside derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990601